STOCKSERVICES-MISC HEALTH & ALLIED SERVICES, NECUpdated 2026-07-26
Here’s whether Sotera Health Company Common Stock (SHC) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+2.66% over 10 days); RSI 44 — healthy momentum range; strong 1-year return of +43.3%; 3-month momentum positive (+11.4%). Currently 12.6% off its 52-week high. Score: +7/7.
SHC is in a confirmed uptrend, trading above both its 50-day ($16.59) and 200-day ($16.43) moving averages. An RSI of 43.8 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +43.3% compares to +16.5% for SPY (beat the market by 26.8%).
$10,000 invested 1 year ago→ $14,327 today
vs. S&P 500 (SPY) — same period beat market by 26.8%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($16.43)
✓Above 50-day MA ($16.59)
✓RSI(14) neutral zone (30–70) — currently 43.8
✓Positive return (+43.3%)
!Within 10% of period high (−12.6%)
Period Range $17.35
$11.00$19.85
RSI (14) 43.8
0 · OversoldOverbought · 100
Key Metrics
Price$17.35
Period Return+43.3%
Period High$19.85
Period Low$11.00
Drawdown−12.6%
MA-50$16.59
MA-200$16.43
RSI (14)43.8
Avg Volume (30d)2.8M
vs. SPYbeat by 26.8%
Return Rank#241 of 999
Trend Signals
Price is above the 200-day moving average ($16.43)